Concord Drugs Ltd share price logo

Concord Drugs Share Price

BSE: 538965

Small Cap

Healthcare Sector

₹71.87

+0.27

(+0.38%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Concord Drugs Stock Performance

as on March 27, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹70.00
    ₹73.70
    downward going graph

    2.60%

    Downside

    2.55%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹29.00
    ₹92.52
    downward going graph

    59.65%

    Downside

    28.73%

    Upside

    downward going graph

Concord Drugs share price movements today

Previous Close
₹71.60
Open
₹73.70
Volume
1,661.00
Upper Circuit
₹75.18
Lower Circuit
₹68.02
Day's Low - High
₹70.00 - ₹73.70
52 Week Low - High
₹29.00 - ₹92.52

Concord Drugs Historical Returns

1 Month Return
-9.37 %
3 Month Return
-13.85 %
1 Year Return
+ 132.77 %
3 Year Return
+ 165.28 %
5 Year Return
+ 144.37 %

Concord Drugs Fundamentals

as on March 27, 2026 at 4:01 pm IST

Market Cap

₹71.60 Cr

Return on Equity (ROE)

0.88

PE Ratio (TTM)

140.39

Return on capital employed (ROCE)

4.49

Industry PE ratio

40.67

Beta (LTM)

0.52

P/B Ratio

0.91

Dividend Yield

0

PEG Ratio

255.26

Quarterly Earnings Growth YOY

-4.35

EPS (TTM)

0.34

Sector

Pharmaceuticals

Book Value

34.11

Technical Analysis

Bearish

View Technical Analysis

Concord Drugs Stock Valuation

as on March 27, 2026 at 4:01 pm IST

Concord Drugs in the last 5 years

  • Overview

  • Trends

Lowest (-961.50x)

January 3, 2025

Industry (40.67x)

March 25, 2026

Today (140.39x)

March 25, 2026

Highest (791.40x)

July 3, 2024

LowHigh

Today’s Price to Earnings Ratio: 140.39x

Concord Drugs Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Concord Drugs with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Concord Drugs Ltd image
Concord Drugs Ltd
NA71.6028.87%0.70145
Welcure Drugs & Pharmaceuticals Ltd image
Welcure Drugs & Pharmaceuticals Ltd
NA32.1310.59%0.00NANA
Amrutanjan Health Care Ltd image
Amrutanjan Health Care Ltd
NA1,501.04-1.23%0.00NANA
Zim Laboratories Ltd image
Zim Laboratories Ltd
NA341.06-2.04%0.6612379
Denis Chem Lab Ltd image
Denis Chem Lab Ltd
NA87.8712.81%0.008173
See all

Concord Drugs Stock’s Investor Sentiment and Interest

Search interest for Concord Drugs Ltd Stock has decreased by -57% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-57% versus previous 30 day period

Concord Drugs Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
12.31
8.98
7.52
12.78
15.64
11.69
12.36
10.8
10.39
13.61
10.28
16.97
Total Income
12.31
8.98
7.52
12.78
15.64
11.69
12.37
10.8
10.4
13.61
10.28
16.99
Expenses
11.34
7.52
5.91
12.15
15.29
10.86
11.49
9.41
9.35
12.59
9.18
16.05
Operating Profit
0.97
1.46
1.61
0.63
0.35
0.83
0.87
1.39
1.04
1.02
1.1
0.92
Operating Profit Margin %
7.88%
16.26%
21.41%
4.93%
2.24%
7.1%
7.04%
12.87%
10.01%
7.49%
10.7%
5.42%
Profit Before Interest, Tax and Depreciation
0.97
1.46
1.61
0.63
0.35
0.83
0.88
1.39
1.05
1.02
1.1
0.94
Interest
0.5
0.44
0.43
0.5
0.5
0.45
0.47
0.5
0.61
0.49
0.49
0.34
Depreciation
0.33
0.38
0.39
0.39
0.39
0.34
0.34
0.37
0.38
0.37
0.34
0.31
Profit Before Tax
0.14
0.64
0.79
-0.26
-0.54
0.04
0.07
0.52
0.06
0.16
0.27
0.29
Tax Paid
-0.03
0.15
0.24
-0.01
-0.21
0.02
0.03
0.31
0.02
0.04
0.08
0.08
Profit After Tax
0.16
0.49
0.56
-0.24
-0.34
0.03
0.04
0.23
0.04
0.12
0.19
0.22
Total Net profit including share of profit / Loss from associate company
0.16
0.49
0.56
-0.24
-0.34
0.03
0.04
0.23
0.04
0.12
0.19
0.22
EPS
0.17
0.53
0.6
-0.24
-0.34
0.03
0.04
0.23
0.04
0.12
0.19
0.16
Actual EPS
0.17
0.53
0.6
-0.24
-0.34
0.03
0.04
0.23
0.04
0.12
0.19
0.16
Adjusted EPS
0.17
0.53
0.6
-0.24
-0.34
0.03
0.04
0.23
0.04
0.12
0.19
0.16
Diluted EPS
0.17
0.53
0.6
-0.24
-0.34
0.03
0.04
0.23
0.04
0.12
0.19
0.16

Concord Drugs Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
58.96
52.08
44.92
45.24
Total Income
59.06
52.09
44.93
45.26
Expenses
53.36
47.51
40.88
41.11
Operating Profit
5.6
4.57
4.04
4.13
Operating Profit Margin %
9.5%
8.77%
8.99%
9.13%
Profit Before Interest, Tax and Depreciation
5.69
4.58
4.05
4.15
Interest
1.68
1.71
1.87
2.03
Depreciation
1.76
1.63
1.56
1.43
Profit Before Tax
2.25
1.24
0.62
0.69
Tax Paid
0.65
0.26
0.16
0.35
Profit After Tax
1.59
0.99
0.47
0.34
Total Net profit including share of profit / Loss from associate company
1.59
0.99
0.47
0.34
EPS
1.82
1.06
0.47
0.34
Actual EPS
1.82
1.06
0.47
0.34
Adjusted EPS
1.82
1.06
0.47
0.34
Diluted EPS
1.82
1.06
0.47
0.34

Concord Drugs Ltd Cash Flow

Figures in Rupees Crores

Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
0.77
1.66
0.79
3.72
Cash Flow from Investing Activities
0.01
-1.41
0.01
0.01
Cash Flow from Financing Activities
1.68
0.62
0.27
-1.43
Net Cash Flow
0.01
0.02
0.07
-0.02

Concord Drugs Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Oct 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Nov 2025
Dec 2025
Promoters
52.13%
52.13%
55.41%
55.41%
55.41%
55.41%
54.39%
54.39%
54.39%
54.39%
54.39%
45.08%
54.39%
Public
47.87%
47.87%
44.59%
44.59%
44.59%
44.59%
45.61%
45.61%
45.61%
45.61%
45.61%
54.92%
45.61%
Total Outstanding Shares
93,15,470
93,15,470
1,00,00,000
1,00,00,000
1,00,00,000
1,00,00,000
1,00,00,000
1,00,00,000
1,00,00,000
1,00,00,000
1,00,00,000
1,31,75,000
1,00,00,000
Total Shareholders
3,198
3,957
3,963
4,032
4,734
4,755
5,073
5,073
5,252
5,189
4,718
4,597
4,597

Concord Drugs Corporate Actions

View detailed summary of the earnings and dividend history of Concord Drugs.

  • Concord Drugs Ltd Earnings Results

    Concord Drugs Ltd’s net profit fell -4.35% since last year same period to ₹0.22Cr in the Q3 2025-2026. On a quarterly growth basis, Concord Drugs Ltd has generated 15.79% jump in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Concord Drugs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, Concord Drugs stock has moved up by 132.8%

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 45.08% to 54.39% in Dec 2025 quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, Concord Drugs has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, 0.04 Cr → 0.22 Cr (in ₹), with an average increase of 39.1% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 10.28 Cr → 16.99 Cr (in ₹), with an average increase of 39.5% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 179.8% return, outperforming this stock by 14.5%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 54.92% to 45.61% in Dec 2025 quarter

About Concord Drugs Ltd

Concord Drugs Limited, established in 1995, is one of the most reputable pharmaceutical companies in India that manufactures Finished Pharmaceutical Formulations such as Injectables, Small Volume Parenterals, Dry Powder, Tissue BioAdhesive Tablets, Capsules and Ophthalmic Preparations, and Readytofill Pellets. They specialize in cGMP contract manufacturing and FormulationFillFinish facility providing comprehensive pharmaceutical development and manufacturing services for drug products. Through the use of state-of-the-art technology that ensures the highest level of process integrity and product quality, they strive to provide their customers with an end-to-end solution to their various pharmaceutical product needs. In order to meet the standards set by regulatory bodies, their two manufacturing facilities are designed to comply with the prerequisites of these governing bodies.

Revenue: ₹16.97Cr as on December 2025 (Q3 FY26)
Net Profit: ₹0.22Cr as on December 2025 (Q3 FY26)
Chairperson Name: S Nagi Reddy
OrganisationConcord Drugs Ltd
IndustryPharmaceuticals
CEOS Nagi Reddy
E-voting on sharesClick here to vote

FAQs

What is Concord Drugs share price today?

Concord Drugs share price today stands at ₹71.87 as on at the close of the market. Concord Drugs share today touched a day high of ₹73.7 and a low of ₹70.

What is the 52 week high and 52 week low range for Concord Drugs share?

Concord Drugs touched a 52 week high of ₹92.52 and a 52 week low of ₹29. Concord Drugs share price today i.e. is closed at ₹71.87, which is -22.32% down from its 52 week high and 147.83% up from its 52 week low.

What is Concord Drugs's market capitalisation today?

Concord Drugs market capitalisation is ₹71.60 Cr as on .

How to buy Concord Drugs shares?

To buy Concord Drugs shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 538965 or Concord Drugs Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Concord Drugs shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Concord Drugs trading volume today?

Concord Drugs trading volume is 1,661.00 as on . This means that 1,661.00 shares of Concord Drugs were bought and sold on the stock market during today's trading session.